Aurobindo Pharma has received USFDA approval for Dapagliflozin and Metformin tablets used to treat Type-2 diabetes, with plans to launch the product immediately in the US market.
Aurobindo Pharma has received USFDA approval for Dapagliflozin and Metformin tablets used to treat Type-2 diabetes, with plans to launch the product immediately in the US market.